HOME  | CONTACT  | PATIENT LOGIN  | CLINIC LOGIN  | FAQ
  • PATIENTS &
    HEALTHY VOLUNTEERS
  • INVESTIGATORS
  • CROS / SPONSORS
  • CAREERS
  • TRIAL ALERTS

TRIALS SEARCH
      
  • HEALTH NEWS

  • RSS FEEDS

  • ABOUT TRIALS

  • LINK TO US


View Clinical Trial (Medical Research Study)


Randomized Controlled Trial of Xylitol Versus Saline Rinse For Chronic Sinusitis

Signup
Browse Studies

City:   Iowa City
State:   Iowa
Zip Code:   52242
Conditions:   Chronic Sinusitis
Purpose:   In this pilot study, the investigators plan to compare the efficacy of twice daily xylitol nasal rinse with saline rinse which is the current standard, on outcomes such as quality of life and exacerbations.
Study Summary:  
Criteria:   We now have two arms to this study. Group I: Immunocompetent subjects with chronic rhinosinusitis Inclusion Criteria: - 56 Adult subjects (18 or older) presenting to the ENT clinics who meet the diagnosis of chronic rhinosinusitis (CRS). Definition of CRS: Presence of at least 2 of the following 4 signs/symptoms for 12 weeks or longer despite medical management: - Anterior and/or posterior mucopurulent drainage - Nasal obstruction - Facial pain, pressure, and/or fullness - Decreased sense of smell - In addition, objective evidence of sinus mucosal disease must be demonstrated on sinus CT imaging or direct endoscopic examination. Exclusion Criteria: - Cystic fibrosis - Fungal sinusitis - Immunocompromised status (use of long term oral steroids (> 30 days), AIDS, active malignancy or chemotherapy) - Known Ciliary disorders - Sinonasal tumors - Pregnancy Group 2: CRS with antibody deficiency - 56 Adult subjects (18 or older) presenting to the Allergy clinic who meet the diagnosis of chronic rhinosinusitis (CRS). Definition of CRS: Presence of at least 2 of the following 4 signs/symptoms for 12 weeks or longer despite medical management: - Anterior and/or posterior mucopurulent drainage - Nasal obstruction - Facial pain, pressure, and/or fullness - Decreased sense of smell - In addition, objective evidence of sinus mucosal disease must be demonstrated on sinus CT imaging or direct endoscopic examination. Exclusion criteria: Cystic Fibrosis Sinonasal tumors Pregnancy
NCT ID:   NCT00924404
Primary Contact:   Principal Investigator
Lakshmi Durairaj, M.D.
University of Iowa

Backup Contact:   N/A
Location Contact:   Iowa City, Iowa 52242
United States

Janice L Launspach, R.N., CCRC
Phone: 319-356-2047
Email: janice-launspach@uiowa.edu

Site Status: Recruiting

Data Source:   ClinicalTrials.gov
Date Processed:   June 18, 2013
Modifications to this listing:   Only selected fields are shown, please use the link below to view all information about this clinical trial.
Click to view Full Listing


If you would like to be contacted by the clinical trial representative please enter your contact information, then click "I Am Interested In This Study"
First Name:  
Last Name:  
Email Address:  
Confirm Email:    
Daytime Phone (eg. 555-555-5555):  
City:  
State:
Zip Code:    
Best Time to Call:  
Questions/Comments:  
  • NEARBY STUDIES

Within 25 Miles

Arthritis - Cedar Rapids IA

Uncontrolled Angina (Adult Stem Cell Research) - Iowa City IA

Within 50 Miles

Within 100 Miles

 
Clinical Connections Home | Investigators | CROs / Sponsors | Clinical Trials Notification | Search Clinical Trials | About Clinical Trials | Links | Terms And Conditions | Sitemap | Suggestions / Feedback
© 1998-2013 | All trademarks are property of their legal owners. | All Rights Reserved

ClinicalConnection.com is a resource that provides individuals with information regarding clinical trials that are being conducted worldwide.

ClinicalConnection.com does not conduct these clinical trials nor endorse them. Please consult your doctor or physician before participating.